(Q37336471)

19 August 2017

1 reference

title

Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. (English)

1 reference

19 August 2017

Beatrice J Edwards

1

0 references

Dennis West

object named as

Dennis West

15

0 references

Athanasios Dimopoulos

object named as

Meletios Dimopoulos

9

0 references

Mrinal Gounder

2

object named as

Mrinal Gounder

1 reference

19 August 2017

June M McKoy

3

1 reference

19 August 2017

Ian Boyd

4

1 reference

19 August 2017

Mathew Farrugia

5

1 reference

19 August 2017

Cesar Migliorati

6

1 reference

19 August 2017

Robert Marx

7

1 reference

19 August 2017

Salvatore Ruggiero

8

1 reference

19 August 2017

Dennis W Raisch

10

1 reference

19 August 2017

Seema Singhal

11

1 reference

19 August 2017

Ken Carson

12

1 reference

19 August 2017

Eniola Obadina

13

1 reference

19 August 2017

Steve Trifilio

14

1 reference

19 August 2017

Jayesh Mehta

16

1 reference

19 August 2017

Charles L Bennett

17

1 reference

19 August 2017

publication date

1 December 2008

1 reference

Lancet Oncology Commission

19 August 2017

published in

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

12

1 reference

19 August 2017

page(s)

1166-1172

1 reference

The influence of two diphosphonates on calcium metabolism in the rat

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Alendronate treatment of naturally-occurring periodontitis in beagle dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Does alendronate prevent collapse in osteonecrosis of the femoral head?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Zoledronic acid improves femoral head sphericity in a rat model of perthes disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaws associated with cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Bisphosphonate mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

The dental implications of bisphosphonates and bone disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the jaw associated with pamidronate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Bisphosphonate-associated osteonecrosis of the auditory canal

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

ASCO 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma: Guideline Summary

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Thalidomide-associated deep vein thrombosis and pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Pure red-cell aplasia and epoetin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

The Research on Adverse Drug Events and Reports (RADAR) project.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

Thrombotic thrombocytopenic purpura after stenting and ticlopidine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970305-X

7 January 2021

10.1016/S1470-2045(08)70305-X

Identifiers

DOI

1 reference

19 August 2017

1 reference